Search results for #GImalignancies
Join @YJanjigianMD, @DrShubhamPant & Dr. Strickler as they discuss treatment plans with HER2-targeted therapies for #GImalignancies & where these options fit in current guideline recommendations. 5/31 at 6:30 PM CDT at #ASCO24! With @curecc & @CCAlliance: bit.ly/2024GIT
Understand the evidence that supports biomarker testing and targeted therapies for the treatment of HER2+ #GImalignancies. 5/31 during #ASCO24 with @YJanjigianMD & John Strickler, MD! Produced with @curecc & @CCAlliance: bit.ly/2024GIT
In the latest episode of Oncology Overdrive: @MGHCancerCenter’s @aparna1024 talks with host @ShikhaJainMD about accessibility to screening for #GIoncology and #GImalignancies in the #globalhealthcare space. Listen now: healio.com/news/hematolog…
In the latest episode of Oncology Overdrive: @MGHCancerCenter’s @aparna1024 talks with host @ShikhaJainMD about accessibility to screening for #GIoncology and #GImalignancies in the #globalhealthcare space. Listen now: healio.com/news/hematolog…
Visit our website apgcs.com for all the thrilling details and updates! #precisiononcology #colorectalcancer #singapore #apgcs2024 #gicancer #gastroenterology #immunotherapy #gimalignancies #pancreaticcan
Last chance to register for PER's live satellite symposium on mCRC! Don't miss out on earning free CE/CME. Register now: bit.ly/3O1Wy70 #gotoPER #ASCOGI #GImalignancies #ASCOGI24
Among women, #breastcancer -commonest primary malignancy associated w cutaneous metastases Our male patients had #GImalignancies & #headandneckmalignacies 2/
'Targeting #KRAS has been one of the holy grails in #oncology' @BenWestphalen, MD, @LMU_Muenchen gives us his thoughts on the progress made in targeting #KRAS in #GImalignancies 🎥 Find out more about the importance of #genomic #biomarkers in #mCRC 🗞️ 👉 vjoncology.com/feature/genomi…
Excellent review by PhD Morelli at #ASCO23 about the landscape of immune bases approaches for #GImalignancies and how novel immune check point inhibitors could provide synergistic effect with PD1/PD-L1 and CTLA-4 inhibitors, without increased toxicity.😁👏 @ASCO
REGISTERATIONS ARE ONGOING: apgcs.com/registration/ #apgcs2023 #gicancer #gastroenterology #immunotherapy #gimalignancies #pancreaticcancer
Click Here lnkd.in/d9QHAiDG to Submit Interest and Reserve your Seats! #apgcs2022 #gicancer #gastroenterology #immunotherapy #gimalignancies #pancreaticcancer #precisiononcology #colorectalcancer #singapore
Kicking off tonight’s @OncLiveSOSS @OncLive @MayoCancerCare @GIcancerDoc introduces @the_danielahn #gimalignancies #gism
Diagnostic Performance of AI-Centered Systems in the Diagnosis and Postoperative Surveillance of Upper #GIMalignancies Using CT Imaging: Review and Meta-Analysis @cswathikan rdcu.be/cI722 #VisualAbstract @McMastersKelly
To kick-off our Best of Oncology Conference virtual recaps, the first session highlighted Melanoma, Sarcoma, GI & Gynecologic Malignancies. @ASCO #bestofoncology #asco #ccaboo21 #oncology #melanoma #sarcoma #gimalignancies #gynecologicmalignancies youtu.be/sIkZ-qYpIPs
Categories of #pancreaticcancer include resectable, borderline resectable, and unresectable says Dr Zev Wainberg @OncLiveSOSS #ipc #gimalignancies @UCLAJCCC big trials ongoing are the NCT, Alliance, and PRODIGE.
See a new #GIMalignancies activity via @PeerView @agrothey @KoheiShitara #GICancer api.learn2.peerview.com/psocial/share/…
SWOG SL505 had a mixed bag of patients with some borderline resectable says @CardinMD in #pancreaticcancer patients #pancan @OncLiveSOSS #ipc #gimalignancies @VUMChealth w/chairs @CathyEngMD @jordanberlin5 addtl imp study is Alliance A02150
